Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-034601

Chief Business Officer sold 42,865 shares at an average $8.73 ($374,034)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Virani Shafique · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-01 Sale : show line 1 in the form 10b5-1 −25,000 $8.58 $214,500 161,819 D
2023-06-02 Sale : show line 2 in the form 10b5-1 −17,865 $8.93 $159,534 143,954 D
Open-market sales · 42,865 sh · avg $8.73 · $374,034
Loading xslF345X04/doc4.xml…